BioForce Nanosciences (OTCMKTS:BFNH – Get Free Report) released its quarterly earnings data on Monday. The company reported ($0.01) earnings per share (EPS) for the quarter, Zacks reports.
BioForce Nanosciences Trading Down 1.3%
BioForce Nanosciences stock opened at $6.60 on Wednesday. The firm has a market cap of $251.33 million, a price-to-earnings ratio of 660.17 and a beta of 0.79. The stock has a fifty day simple moving average of $7.76 and a two-hundred day simple moving average of $2.83. BioForce Nanosciences has a 12 month low of $0.18 and a 12 month high of $10.99.
About BioForce Nanosciences
BioForce Nanosciences, Inc. developed nanotechnology tools and systems for life-science and biotechnology applications. Its technology was designed to manipulate, deposit and analyze very small quantities of biological materials, supporting research in areas such as proteomics, genomics, diagnostics and drug discovery. The company’s product portfolio included the Nano eNabler molecular printer, a platform intended to create precise arrays of proteins, DNA and other biomolecules on laboratory substrates.
Read More
- Five stocks we like better than BioForce Nanosciences
- 3 Stocks Wall Street Likes More Than the Market Does
- Anthropic’s Trillion-Dollar IPO Could Give Cloud Giants a Double Win
- The AI Debt Bill Is Coming Due, But Biotech Has Revenue to Show for the Boom
- 3 Insider Selling Stories; 3 Different Signals for Investors
Receive News & Ratings for BioForce Nanosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioForce Nanosciences and related companies with MarketBeat.com's FREE daily email newsletter.
